Citigroup
BIOA

Citigroup’s BioAge Labs BIOA Stock Holding History

Citigroup’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Buy
13,384
+11,846
+770% +$228K ﹤0.01% 3939
2025
Q4 		$20.3K Buy
1,538
+1,262
+457% +$11.2K ﹤0.01% 4867
2025
Q3 		$1.62K Sell
276
-10,882
-98% -$51K ﹤0.01% 5534
2025
Q2 		$46.1K Buy
11,158
+2,621
+31% +$10.6K ﹤0.01% 4803
2025
Q1 		$32.1K Sell
8,537
-1,018
-11% -$4.71K ﹤0.01% 4996
2024
Q4 		$55.3K Buy
+9,555
New +$165K ﹤0.01% 5060

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citigroup's BIOA Position: Q1 2026 in Review

Citigroup increased its BioAge Labs (BIOA) stake by 770% in Q1 2026, buying an estimated $228K and bringing the position to 13,384 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #3939.

Citigroup first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Citigroup held 13,384 shares of BioAge Labs worth $234K as of Q1 2026.
  • Citigroup bought 11,846 BioAge Labs shares in Q1 2026, an estimated $228K.
  • BioAge Labs made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3939 holding.
  • Citigroup first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.